APOA1 and colorectal carcinoma: A different study using a prospective cohort study design assessed the serum lipoprotein levels at baseline and then over repeated assessments that explored the correlation between different apolipoprotein concentrations and tumor subsites of colorectal cancer (CRC) patients; it was observed that there is no statistical significance between the concentration of APOA and early-, middle-, or late-onset CRC.